Literature DB >> 32254722

Albumin conjugates and assemblies as versatile bio-functional additives and carriers for biomedical applications.

Chao Tao1, Yon Jin Chuah, Chenjie Xu, Dong-An Wang.   

Abstract

As the most abundant plasma protein, serum albumin has been extensively studied and employed for therapeutic applications. Despite its direct clinical use for the maintenance of blood homeostasis in various medical conditions, this review exclusively summarizes and discusses albumin-based bio-conjugates and assemblies as versatile bio-functional additives and carriers in biomedical applications. As one of the smallest-sized proteins in the human body, albumin is physiochemically stable and biochemically inert. Moreover, albumin is also endowed with abundant specific binding sites for numerous therapeutic compounds, which also endow it with superior bioactivities. Firstly, due to its small size and binding specificity, albumin alone or its derived assemblies can be utilized as competent drug carriers, which can deliver drugs through the enhanced permeability and retention (EPR) effect or actively target lesion sites through binding with gp60 and secreted protein acidic and rich in cysteine (SPARC) in tumor sites. Furthermore, its biochemical stability and inertness make it a safe and biocompatible coating material for use in biomedical applications. Albumin-based surface modifying additives can be used to functionalize both macro substrates (e.g. surfaces of medical devices or implants) and nanoparticle surfaces (e.g. drug carriers and imaging contrast agents). In this review, we elaborate on the synthesis and applications of albumin-based bio-functional coatings and drug carriers, respectively.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 32254722     DOI: 10.1039/c8tb02477d

Source DB:  PubMed          Journal:  J Mater Chem B        ISSN: 2050-750X            Impact factor:   6.331


  10 in total

1.  Albumin-Binding Aptamer Chimeras for Improved siRNA Bioavailability.

Authors:  Jonah C Rosch; Ella N Hoogenboezem; Alexander G Sorets; Craig L Duvall; Ethan S Lippmann
Journal:  Cell Mol Bioeng       Date:  2022-01-24       Impact factor: 2.321

2.  Dual Coating of Chitosan and Albumin Negates the Protein Corona-Induced Reduced Vascular Adhesion of Targeted PLGA Microparticles in Human Blood.

Authors:  Genesis Lopez-Cazares; Omolola Eniola-Adefeso
Journal:  Pharmaceutics       Date:  2022-05-09       Impact factor: 6.525

3.  Improvement of efficacy and decrement cytotoxicity of oxaliplatin anticancer drug using bovine serum albumin nanoparticles: synthesis, characterisation and release behaviour.

Authors:  Vahid Ziaaddini; Maryam Saeidifar; Mahboubeh Eslami-Moghadam; Mandana Saberi; Masoud Mozafari
Journal:  IET Nanobiotechnol       Date:  2020-02       Impact factor: 1.847

4.  Antibacterial Albumin-Tannic Acid Coatings for Scaffold-Guided Breast Reconstruction.

Authors:  Silvia Cometta; Nathalie Bock; Sinduja Suresh; Tim R Dargaville; Dietmar W Hutmacher
Journal:  Front Bioeng Biotechnol       Date:  2021-03-31

Review 5.  Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review.

Authors:  Sofia Teixeira; Maria Alice Carvalho; Elisabete M S Castanheira
Journal:  Biomedicines       Date:  2022-02-18

6.  HSA-Binding Prodrugs-Based Nanoparticles Endowed with Chemo and Photo-Toxicity against Breast Cancer.

Authors:  Valentina Rapozzi; Francesca Moret; Luca Menilli; Andrea Guerrini; Daniele Tedesco; Marina Naldi; Manuela Bartolini; Mariachiara Gani; Sonia Zorzet; Marta Columbaro; Celeste Milani; Cecilia Martini; Claudia Ferroni; Greta Varchi
Journal:  Cancers (Basel)       Date:  2022-02-10       Impact factor: 6.639

7.  Radionuclide 131I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer.

Authors:  Xuemei Zhang; Ziyu Yan; Zhaowei Meng; Ning Li; Qiang Jia; Yiming Shen; Yanhui Ji
Journal:  Front Oncol       Date:  2022-07-25       Impact factor: 5.738

8.  Enhanced Uptake and Phototoxicity of C60@albumin Hybrids by Folate Bioconjugation.

Authors:  Andrea Cantelli; Marco Malferrari; Edoardo Jun Mattioli; Alessia Marconi; Giulia Mirra; Alice Soldà; Tainah Dorina Marforio; Francesco Zerbetto; Stefania Rapino; Matteo Di Giosia; Matteo Calvaresi
Journal:  Nanomaterials (Basel)       Date:  2022-10-06       Impact factor: 5.719

9.  Catechin-Albumin Conjugates: Enhanced Antioxidant Capacity and Anticancer Effects.

Authors:  Tooru Ooya; Izumi Haraguchi
Journal:  Int J Food Sci       Date:  2022-10-08

10.  Hyaluronic-Coated Albumin Nanoparticles for the Non-Invasive Delivery of Apatinib in Diabetic Retinopathy.

Authors:  Salma El-Sayed Radwan; Amal El-Kamel; Eiman I Zaki; Susi Burgalassi; Erica Zucchetti; Riham M El-Moslemany
Journal:  Int J Nanomedicine       Date:  2021-07-02
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.